Navigation Links
It is possible to have stem cell based treatment for eye problems now

Researchers have been able to discover a new molecular structure that may be// used to treat eye problems like retinal degeneration using stem cell technology.

The research had lead to the discovery of a protein called GDF11 that controls an important part of retinal cell differentiation during the developmental stage. This may make it possible to target the protein to replace any lost retinal cells by using the stem cell technology to create new retinal cells.

Stem cells are undifferentiated cells that have the potential to regenerate self and develop into all types of specialized cells types that may form various types of cells of the tissue from which it was taken.

Researchers are hopeful that their research findings will open the door to devise therapy procedures that will make it possible to restore vision in people who have lost their sense to see because of loss of certain retinal cell types. Drawing parallels from their animal study, the research scientists report that retinal therapy based on the newly discovered protein is possible as the retina contains its own stem cells that can be used to regenerate the cells need to bring back vision to the eyes.

Reference: Science, June 2005
'"/>




Page: 1

Related medicine news :

1. Borderline blood pressure- possible health risk
2. Depression a possible danger in elderly
3. Use of zinc supplements tied to possible increase in risk of prostate cancer
4. Return of SARS possible this fall
5. New treatment possible for drug addiction
6. Early identification of autism possible
7. Early diagnosis for autism from blood tests may be possible
8. Cloning of human embryos for stem cells made possible
9. Injury to knee may result in arthritis, but it is possible to prevent it
10. Treatment for chemobrain may be possible
11. Early detection of bed sores possible
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: